Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
03 October 2018 | Story UFS | Photo Varsity Sports
First ever netball final in Bloemfontein
The Kovsies will be aiming to lift the Varsity Netball trophy in front of their home supporters on Monday when they face Tuks in the final in the Callie Human Centre.
The netball team of the University of the Free State, once again after five years, earned themselves the right to stage a final in the Varsity Netball competition. The two-time champion, the Dream Team, qualified for the final after topping the log and then wiping the floor with the Maties on Monday (1 October 2018) in the semi-final. The score was 56-45. 

They will come up against Tuks in the Callie Human Centre on the UFS Bloemfontein Campus for the final tonight. The match will get underway at 18:45.

The team won the very first two years of the competition in 2013 and 2014. On both occasions, they had to play away from home – in 2013 against the Pukke in Potchefstroom and in 2014 against Tuks in Pretoria. 

It will be the fourth meeting between the Kovsies and Tuks within three months. The Free State students won the group fixture in August by 68-43, but Tuks had to do without a number of their star players. At the University Sport South Africa tournament in Bloemfontein during July, Tuks triumphed twice, winning the final by 48-30.

Apart from the winners’ medals, an award will be handed to the tournament’s top player. Centre Khanyisa Chawane is one of three finalists. The winner gets chosen through public votes.

Dream Team players have won the prize four of the five times. Ané Botha was crowned in 2013, Karla Pretorius in 2014 and 2015, and last year it was the turn of current Kovsie player, Khomotso Mamburu.

To vote for Chawane, click here hover your mouse over the like button and choose the heart emoticon. Voting is closing on 5 October and the winner will be announced after the final.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept